| Preview | Issue Date | Title | Author(s) |
| 2021 | A comprehensive molecular and clinical analysis of the piRNA pathway genes in ovarian cancer | Lee, E.; Lokman, N.A.; Oehler, M.K.; Ricciardelli, C.; Grutzner, F. |
| 2018 | A craniosynostosis massively parallel sequencing panel study in 309 Australian and New Zealand patients: findings and recommendations | Lee, E.; Le, T.; Zhu, Y.; Elakis, G.; Turner, A.; Lo, W.; Venselaar, H.; Verrenkamp, C.A.; Snow, N.; Mowat, D.; Kirk, E.P.; Sachdev, R.; Smith, J.; Brown, N.J.; Wallis, M.; Barnett, C.; McKenzie, F.; Freckmann, M.L.; Collins, F.; Chopra, M.; et al. |
| 2015 | Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma | Whiteman, D.; Appleyard, M.; Bahin, F.; Bobryshev, Y.; Bourke, M.; Brown, I.; Chung, A.; Clouston, A.; Dickins, E.; Emery, J.; Eslick, G.; Gordon, L.; Grimpen, F.; Hebbard, G.; Holliday, L.; Hourigan, L.; Kendall, B.; Lee, E.; Levert-Mignon, A.; Lord, R.; et al. |
| 2015 | Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice | Lee, E.; Yee, D.; Busfield, S.; McManus, J.; Cummings, N.; Vairo, G.; Wei, A.; Ramshaw, H.; Powell, J.; Lopez, A.; Lewis, I.; McCall, M.; Lock, R. |
| 2009 | Monoclonal antibody-mediated targeting of CD123, IL-3 receptor α chain, eliminates human acute myeloid leukemic stem cells | Jin, L.; Lee, E.; Ramshaw, H.; Busfield, S.; Peoppl, A.; Wilkinson, L.; Guthridge, M.; Thomas, D.; Barry, E.; Boyd, A.; Gearing, D.; Vairo, G.; Lopez, A.; Dick, J.; Lock, R. |
| 2021 | Reduced gonadotrophin receptor expression is associated with a more aggressive ovarian cancer phenotype | Cheung, J.; Lokman, N.A.; Abraham, R.D.; Macpherson, A.M.; Lee, E.; Grutzner, F.; Ghinea, N.; Oehler, M.K.; Ricciardelli, C. |
| 2013 | Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription | Thomas, D.; Powell, J.; Vergez, F.; Segal, D.; Nguyen, N.; Baker, A.; Teh, T.; Barry, E.; Sarry, J.; Lee, E.; Nero, T.; Jabbour, A.; Giovanna, P.; Green, B.; Manenti, S.; Glaser, S.; Parker, M.; Lopez, A.; Ekert, P.; Lock, R.; et al. |
| 2014 | Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC | Busfield, S.; Biondo, M.; Wong, M.; Ramshaw, H.; Lee, E.; Ghosh, S.; Braley, H.; Panousis, C.; Roberts, A.; He, S.; Thomas, D.; Fabri, L.; Vairo, G.; Lock, R.; Lopez, A.; Nash, A. |
